Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine
We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens (NAc) dopamine (DA) following acute administration of methamphetamine, heroin, or ethanol. Methamphetamine (2.5 mg/kg) produced a dose‐dependen...
Gespeichert in:
Veröffentlicht in: | Synapse (New York, N.Y.) N.Y.), 1999-10, Vol.34 (1), p.11-19 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 19 |
---|---|
container_issue | 1 |
container_start_page | 11 |
container_title | Synapse (New York, N.Y.) |
container_volume | 34 |
creator | Gerasimov, Madina R. Ashby Jr, Charles R. Gardner, Eliot L. Mills, Mark J. Brodie, Jonathan D. Dewey, Stephen L. |
description | We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens (NAc) dopamine (DA) following acute administration of methamphetamine, heroin, or ethanol. Methamphetamine (2.5 mg/kg) produced a dose‐dependent increase (2,700%) in NAc DA. GVG preadministration (300 or 600 mg/kg), however, inhibited this response by approximately 39 and 61%, respectively. The lower dose of methamphetamine (1.25 mg/kg), increased DA by 1,700%. This response was inhibited to a similar extent (44%) regardless of the GVG dose preadministered (300 or 600 mg/kg). In addition, heroin‐induced increases in NAc DA (0.5 mg/kg, 170%) were inhibited or completely abolished by GVG (150 or 300 mg/kg, 65 and 100%, respectively). Finally, at half the dose necessary for heroin, GVG (150 mg/kg) also completely abolished ethanol‐induced increases in NAc DA following a 0.25 g/kg challenge dose (140%). Taken with our previous findings using nicotine or cocaine as the challenge drug, these results indicate that GVG attenuates increases in NAc DA by a mechanism common to many drugs of abuse. However, it appears unlikely that an acute dose of GVG can completely inhibit increases in NAc DA following challenges with a drug whose mechanism of action is mediated primarily through the DA reuptake site. Synapse 34:11–19, 1999. © 1999 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69993833</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17509396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4282-9348286d94f0bd2b22c7ac3a9c46c52811df7e0437b54da5d44e1e86ccd123db3</originalsourceid><addsrcrecordid>eNqFkV9v0zAUxS0EYmXwFVCe0CYtxdd2_rhDSCWwUmlakQoCnq4c21XN4qTEDdBvT7JMAwkEL762fO7vSOcQcg50CpSy5yfrZbE8BSrzmHGZnoCUEugpFzN4ATCbzZev4_XnK_aST-m0WJ2zOLlHJnf6-2RC8zyLhcjSI_IohC-UUg5UPCRH_ZlISLMJ8QvlvYq_ufpQRYv5q3nk6q0r3T5E3u63yu-2dq-8q-1ZtLVt4-qzqGmj4atuqtjVptPW9Eu6tSrY0N-iutOV7UKktO58aesQmWZ3w3hMHmxUFeyT23lMPly8eV-8jS9Xi2Uxv4y1YDmLJRc5y1MjxYaWhpWM6UxprqQWqU5YDmA2maWCZ2UijEqMEBZsnmptgHFT8mPybOTu2uZrZ8MevQvaVpWqbdMFTPsoec75f4WQJVT2YfbC9SjUbRNCaze4a51X7QGB4lAX4lAXDvHjED-OdSEXCAiA2NeFQ13IkWKxQoZJT316a9-V3prfmGM_v2y_u8oe_vD8t-VfHG_ePTUeqS7s7Y87qmqvsffMEvx4tcBPUAC_eLfGgv8Ej9y_Fw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17509396</pqid></control><display><type>article</type><title>Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Gerasimov, Madina R. ; Ashby Jr, Charles R. ; Gardner, Eliot L. ; Mills, Mark J. ; Brodie, Jonathan D. ; Dewey, Stephen L.</creator><creatorcontrib>Gerasimov, Madina R. ; Ashby Jr, Charles R. ; Gardner, Eliot L. ; Mills, Mark J. ; Brodie, Jonathan D. ; Dewey, Stephen L.</creatorcontrib><description>We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens (NAc) dopamine (DA) following acute administration of methamphetamine, heroin, or ethanol. Methamphetamine (2.5 mg/kg) produced a dose‐dependent increase (2,700%) in NAc DA. GVG preadministration (300 or 600 mg/kg), however, inhibited this response by approximately 39 and 61%, respectively. The lower dose of methamphetamine (1.25 mg/kg), increased DA by 1,700%. This response was inhibited to a similar extent (44%) regardless of the GVG dose preadministered (300 or 600 mg/kg). In addition, heroin‐induced increases in NAc DA (0.5 mg/kg, 170%) were inhibited or completely abolished by GVG (150 or 300 mg/kg, 65 and 100%, respectively). Finally, at half the dose necessary for heroin, GVG (150 mg/kg) also completely abolished ethanol‐induced increases in NAc DA following a 0.25 g/kg challenge dose (140%). Taken with our previous findings using nicotine or cocaine as the challenge drug, these results indicate that GVG attenuates increases in NAc DA by a mechanism common to many drugs of abuse. However, it appears unlikely that an acute dose of GVG can completely inhibit increases in NAc DA following challenges with a drug whose mechanism of action is mediated primarily through the DA reuptake site. Synapse 34:11–19, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0887-4476</identifier><identifier>EISSN: 1098-2396</identifier><identifier>DOI: 10.1002/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5</identifier><identifier>PMID: 10459167</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject><![CDATA[addiction ; Analgesics, Opioid - antagonists & inhibitors ; Analgesics, Opioid - pharmacology ; Animals ; Anticonvulsants - pharmacology ; Central Nervous System Depressants - antagonists & inhibitors ; Central Nervous System Depressants - pharmacology ; dopamine ; Dopamine - cerebrospinal fluid ; Dopamine - metabolism ; Dopamine Uptake Inhibitors - antagonists & inhibitors ; Dopamine Uptake Inhibitors - pharmacology ; ethanol ; Ethanol - antagonists & inhibitors ; Ethanol - pharmacology ; Extracellular Space - metabolism ; g-vinyl ^g-aminobutyric acid ; gamma vinyl-GABA ; gamma-Aminobutyric Acid - analogs & derivatives ; gamma-Aminobutyric Acid - pharmacology ; heroin ; Heroin - antagonists & inhibitors ; Heroin - pharmacology ; Male ; methamphetamine ; Methamphetamine - antagonists & inhibitors ; Methamphetamine - pharmacology ; Microdialysis ; Nucleus Accumbens - drug effects ; Nucleus Accumbens - metabolism ; positron emission tomography ; Rats ; Rats, Sprague-Dawley ; Sabril ; Time Factors ; Vigabatrin]]></subject><ispartof>Synapse (New York, N.Y.), 1999-10, Vol.34 (1), p.11-19</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><rights>Copyright 1999 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4282-9348286d94f0bd2b22c7ac3a9c46c52811df7e0437b54da5d44e1e86ccd123db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291098-2396%28199910%2934%3A1%3C11%3A%3AAID-SYN2%3E3.0.CO%3B2-5$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291098-2396%28199910%2934%3A1%3C11%3A%3AAID-SYN2%3E3.0.CO%3B2-5$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10459167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerasimov, Madina R.</creatorcontrib><creatorcontrib>Ashby Jr, Charles R.</creatorcontrib><creatorcontrib>Gardner, Eliot L.</creatorcontrib><creatorcontrib>Mills, Mark J.</creatorcontrib><creatorcontrib>Brodie, Jonathan D.</creatorcontrib><creatorcontrib>Dewey, Stephen L.</creatorcontrib><title>Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine</title><title>Synapse (New York, N.Y.)</title><addtitle>Synapse</addtitle><description>We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens (NAc) dopamine (DA) following acute administration of methamphetamine, heroin, or ethanol. Methamphetamine (2.5 mg/kg) produced a dose‐dependent increase (2,700%) in NAc DA. GVG preadministration (300 or 600 mg/kg), however, inhibited this response by approximately 39 and 61%, respectively. The lower dose of methamphetamine (1.25 mg/kg), increased DA by 1,700%. This response was inhibited to a similar extent (44%) regardless of the GVG dose preadministered (300 or 600 mg/kg). In addition, heroin‐induced increases in NAc DA (0.5 mg/kg, 170%) were inhibited or completely abolished by GVG (150 or 300 mg/kg, 65 and 100%, respectively). Finally, at half the dose necessary for heroin, GVG (150 mg/kg) also completely abolished ethanol‐induced increases in NAc DA following a 0.25 g/kg challenge dose (140%). Taken with our previous findings using nicotine or cocaine as the challenge drug, these results indicate that GVG attenuates increases in NAc DA by a mechanism common to many drugs of abuse. However, it appears unlikely that an acute dose of GVG can completely inhibit increases in NAc DA following challenges with a drug whose mechanism of action is mediated primarily through the DA reuptake site. Synapse 34:11–19, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>addiction</subject><subject>Analgesics, Opioid - antagonists & inhibitors</subject><subject>Analgesics, Opioid - pharmacology</subject><subject>Animals</subject><subject>Anticonvulsants - pharmacology</subject><subject>Central Nervous System Depressants - antagonists & inhibitors</subject><subject>Central Nervous System Depressants - pharmacology</subject><subject>dopamine</subject><subject>Dopamine - cerebrospinal fluid</subject><subject>Dopamine - metabolism</subject><subject>Dopamine Uptake Inhibitors - antagonists & inhibitors</subject><subject>Dopamine Uptake Inhibitors - pharmacology</subject><subject>ethanol</subject><subject>Ethanol - antagonists & inhibitors</subject><subject>Ethanol - pharmacology</subject><subject>Extracellular Space - metabolism</subject><subject>g-vinyl ^g-aminobutyric acid</subject><subject>gamma vinyl-GABA</subject><subject>gamma-Aminobutyric Acid - analogs & derivatives</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>heroin</subject><subject>Heroin - antagonists & inhibitors</subject><subject>Heroin - pharmacology</subject><subject>Male</subject><subject>methamphetamine</subject><subject>Methamphetamine - antagonists & inhibitors</subject><subject>Methamphetamine - pharmacology</subject><subject>Microdialysis</subject><subject>Nucleus Accumbens - drug effects</subject><subject>Nucleus Accumbens - metabolism</subject><subject>positron emission tomography</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sabril</subject><subject>Time Factors</subject><subject>Vigabatrin</subject><issn>0887-4476</issn><issn>1098-2396</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV9v0zAUxS0EYmXwFVCe0CYtxdd2_rhDSCWwUmlakQoCnq4c21XN4qTEDdBvT7JMAwkEL762fO7vSOcQcg50CpSy5yfrZbE8BSrzmHGZnoCUEugpFzN4ATCbzZev4_XnK_aST-m0WJ2zOLlHJnf6-2RC8zyLhcjSI_IohC-UUg5UPCRH_ZlISLMJ8QvlvYq_ufpQRYv5q3nk6q0r3T5E3u63yu-2dq-8q-1ZtLVt4-qzqGmj4atuqtjVptPW9Eu6tSrY0N-iutOV7UKktO58aesQmWZ3w3hMHmxUFeyT23lMPly8eV-8jS9Xi2Uxv4y1YDmLJRc5y1MjxYaWhpWM6UxprqQWqU5YDmA2maWCZ2UijEqMEBZsnmptgHFT8mPybOTu2uZrZ8MevQvaVpWqbdMFTPsoec75f4WQJVT2YfbC9SjUbRNCaze4a51X7QGB4lAX4lAXDvHjED-OdSEXCAiA2NeFQ13IkWKxQoZJT316a9-V3prfmGM_v2y_u8oe_vD8t-VfHG_ePTUeqS7s7Y87qmqvsffMEvx4tcBPUAC_eLfGgv8Ej9y_Fw</recordid><startdate>199910</startdate><enddate>199910</enddate><creator>Gerasimov, Madina R.</creator><creator>Ashby Jr, Charles R.</creator><creator>Gardner, Eliot L.</creator><creator>Mills, Mark J.</creator><creator>Brodie, Jonathan D.</creator><creator>Dewey, Stephen L.</creator><general>John Wiley & Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>199910</creationdate><title>Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine</title><author>Gerasimov, Madina R. ; Ashby Jr, Charles R. ; Gardner, Eliot L. ; Mills, Mark J. ; Brodie, Jonathan D. ; Dewey, Stephen L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4282-9348286d94f0bd2b22c7ac3a9c46c52811df7e0437b54da5d44e1e86ccd123db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>addiction</topic><topic>Analgesics, Opioid - antagonists & inhibitors</topic><topic>Analgesics, Opioid - pharmacology</topic><topic>Animals</topic><topic>Anticonvulsants - pharmacology</topic><topic>Central Nervous System Depressants - antagonists & inhibitors</topic><topic>Central Nervous System Depressants - pharmacology</topic><topic>dopamine</topic><topic>Dopamine - cerebrospinal fluid</topic><topic>Dopamine - metabolism</topic><topic>Dopamine Uptake Inhibitors - antagonists & inhibitors</topic><topic>Dopamine Uptake Inhibitors - pharmacology</topic><topic>ethanol</topic><topic>Ethanol - antagonists & inhibitors</topic><topic>Ethanol - pharmacology</topic><topic>Extracellular Space - metabolism</topic><topic>g-vinyl ^g-aminobutyric acid</topic><topic>gamma vinyl-GABA</topic><topic>gamma-Aminobutyric Acid - analogs & derivatives</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>heroin</topic><topic>Heroin - antagonists & inhibitors</topic><topic>Heroin - pharmacology</topic><topic>Male</topic><topic>methamphetamine</topic><topic>Methamphetamine - antagonists & inhibitors</topic><topic>Methamphetamine - pharmacology</topic><topic>Microdialysis</topic><topic>Nucleus Accumbens - drug effects</topic><topic>Nucleus Accumbens - metabolism</topic><topic>positron emission tomography</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sabril</topic><topic>Time Factors</topic><topic>Vigabatrin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerasimov, Madina R.</creatorcontrib><creatorcontrib>Ashby Jr, Charles R.</creatorcontrib><creatorcontrib>Gardner, Eliot L.</creatorcontrib><creatorcontrib>Mills, Mark J.</creatorcontrib><creatorcontrib>Brodie, Jonathan D.</creatorcontrib><creatorcontrib>Dewey, Stephen L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Synapse (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerasimov, Madina R.</au><au>Ashby Jr, Charles R.</au><au>Gardner, Eliot L.</au><au>Mills, Mark J.</au><au>Brodie, Jonathan D.</au><au>Dewey, Stephen L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine</atitle><jtitle>Synapse (New York, N.Y.)</jtitle><addtitle>Synapse</addtitle><date>1999-10</date><risdate>1999</risdate><volume>34</volume><issue>1</issue><spage>11</spage><epage>19</epage><pages>11-19</pages><issn>0887-4476</issn><eissn>1098-2396</eissn><abstract>We examined the acute effect of the irreversible GABA‐transaminase inhibitor, gamma‐vinyl GABA (GVG, Sabril®, Vigabatrin®) on increases in nucleus accumbens (NAc) dopamine (DA) following acute administration of methamphetamine, heroin, or ethanol. Methamphetamine (2.5 mg/kg) produced a dose‐dependent increase (2,700%) in NAc DA. GVG preadministration (300 or 600 mg/kg), however, inhibited this response by approximately 39 and 61%, respectively. The lower dose of methamphetamine (1.25 mg/kg), increased DA by 1,700%. This response was inhibited to a similar extent (44%) regardless of the GVG dose preadministered (300 or 600 mg/kg). In addition, heroin‐induced increases in NAc DA (0.5 mg/kg, 170%) were inhibited or completely abolished by GVG (150 or 300 mg/kg, 65 and 100%, respectively). Finally, at half the dose necessary for heroin, GVG (150 mg/kg) also completely abolished ethanol‐induced increases in NAc DA following a 0.25 g/kg challenge dose (140%). Taken with our previous findings using nicotine or cocaine as the challenge drug, these results indicate that GVG attenuates increases in NAc DA by a mechanism common to many drugs of abuse. However, it appears unlikely that an acute dose of GVG can completely inhibit increases in NAc DA following challenges with a drug whose mechanism of action is mediated primarily through the DA reuptake site. Synapse 34:11–19, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>10459167</pmid><doi>10.1002/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0887-4476 |
ispartof | Synapse (New York, N.Y.), 1999-10, Vol.34 (1), p.11-19 |
issn | 0887-4476 1098-2396 |
language | eng |
recordid | cdi_proquest_miscellaneous_69993833 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | addiction Analgesics, Opioid - antagonists & inhibitors Analgesics, Opioid - pharmacology Animals Anticonvulsants - pharmacology Central Nervous System Depressants - antagonists & inhibitors Central Nervous System Depressants - pharmacology dopamine Dopamine - cerebrospinal fluid Dopamine - metabolism Dopamine Uptake Inhibitors - antagonists & inhibitors Dopamine Uptake Inhibitors - pharmacology ethanol Ethanol - antagonists & inhibitors Ethanol - pharmacology Extracellular Space - metabolism g-vinyl ^g-aminobutyric acid gamma vinyl-GABA gamma-Aminobutyric Acid - analogs & derivatives gamma-Aminobutyric Acid - pharmacology heroin Heroin - antagonists & inhibitors Heroin - pharmacology Male methamphetamine Methamphetamine - antagonists & inhibitors Methamphetamine - pharmacology Microdialysis Nucleus Accumbens - drug effects Nucleus Accumbens - metabolism positron emission tomography Rats Rats, Sprague-Dawley Sabril Time Factors Vigabatrin |
title | Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T03%3A40%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gamma-vinyl%20GABA%20inhibits%20methamphetamine,%20heroin,%20or%20ethanol-induced%20increases%20in%20nucleus%20accumbens%20dopamine&rft.jtitle=Synapse%20(New%20York,%20N.Y.)&rft.au=Gerasimov,%20Madina%20R.&rft.date=1999-10&rft.volume=34&rft.issue=1&rft.spage=11&rft.epage=19&rft.pages=11-19&rft.issn=0887-4476&rft.eissn=1098-2396&rft_id=info:doi/10.1002/(SICI)1098-2396(199910)34:1%3C11::AID-SYN2%3E3.0.CO;2-5&rft_dat=%3Cproquest_cross%3E17509396%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17509396&rft_id=info:pmid/10459167&rfr_iscdi=true |